Literature DB >> 15993885

Sex differences in the relation of body composition to markers of inflammation.

Barbara Thorand1, Jens Baumert, Angela Döring, Christian Herder, Hubert Kolb, Wolfgang Rathmann, Guido Giani, Wolfgang Koenig.   

Abstract

OBJECTIVE: It has been suggested that low-grade systemic inflammation is associated with obesity and that this association might be modified by sex. METHODS AND
RESULTS: We performed a cross-sectional analysis among 641 men and 597 women aged 55-74 years who participated in the population-based KORA Survey 2000, conducted in the area of Augsburg, Germany. Measures of both total (fat mass, body mass index) and abdominal adiposity (waist circumference (WC), waist to hip ratio (WHR)) were highly correlated with markers of systemic inflammation (C-reactive protein (CRP), serum amyloid A (SAA), fibrinogen (FIB), interleukin-6 (IL-6)) in men and in women. Significant associations persisted when the effect of lifestyle factors was taken into account. In multivariable linear regression analysis, a considerably higher percentage of variability in inflammatory markers was explained by body composition in women compared to men. Furthermore, the relevance of single body composition variables varied by sex. In women, fat mass in % explained the highest percentage of the variability of circulating acute-phase proteins (18.2% for CRP, 7.2% for SAA, 6.1% for FIB, all p-values < 0.001), whereas in men, WHR explained the highest percentage of the variability (6.2% for CRP, 2.3% for SAA, 1.8% for FIB, all p-values < 0.001). For IL-6, WC explained the highest percentage of the variability in women (3.7%, p < 0.001) and in men (1.8%, p < 0.001).
CONCLUSION: Adiposity is strongly associated with low-grade systemic inflammation in men and in women but the association is considerably stronger in women, especially for CRP. Thus, weight reduction as a means to prevent a state of subclinical inflammation might be particularly effective in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993885     DOI: 10.1016/j.atherosclerosis.2005.04.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  80 in total

1.  Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trial.

Authors:  M Ruiz-Canela; I Zazpe; N Shivappa; J R Hébert; A Sánchez-Tainta; D Corella; J Salas-Salvadó; M Fitó; R M Lamuela-Raventós; J Rekondo; J Fernández-Crehuet; M Fiol; J M Santos-Lozano; L Serra-Majem; X Pinto; J A Martínez; E Ros; R Estruch; M A Martínez-González
Journal:  Br J Nutr       Date:  2015-02-27       Impact factor: 3.718

2.  High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population.

Authors:  K Syvänen; P Korhonen; P Jaatinen; T Vahlberg; P Aarnio
Journal:  Int J Angiol       Date:  2011-03

3.  Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression.

Authors:  Christine M Jewell; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

4.  Sex-Based Differences in Cardiometabolic Biomarkers.

Authors:  Jeanney Lew; Monika Sanghavi; Colby R Ayers; Darren K McGuire; Torbjørn Omland; Dorothee Atzler; Maria O Gore; Ian Neeland; Jarett D Berry; Amit Khera; Anand Rohatgi; James A de Lemos
Journal:  Circulation       Date:  2017-02-07       Impact factor: 29.690

5.  Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.

Authors:  Birgit Klüppelholz; Barbara Thorand; Wolfgang Koenig; Tonia de Las Heras Gala; Christa Meisinger; Cornelia Huth; Guido Giani; Paul W Franks; Michael Roden; Wolfgang Rathmann; Annette Peters; Christian Herder
Journal:  Diabetologia       Date:  2015-07-09       Impact factor: 10.122

6.  Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Authors:  Mitchel A Kling; Salvatore Alesci; Gyorgy Csako; Rene Costello; David A Luckenbaugh; Omer Bonne; Roman Duncko; Wayne C Drevets; Husseini K Manji; Dennis S Charney; Philip W Gold; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2006-12-18       Impact factor: 13.382

7.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

8.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

9.  Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.

Authors:  Pascal Pelletier; Annie Lapointe; Nathalie Laflamme; Marie-Eve Piché; Stanley John Weisnagel; André Nadeau; Simone Lemieux; Jean Bergeron
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

10.  Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Trent L Gaugler; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-17       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.